Werner Scheithauer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vormittag Laurenz; Gleiss Andreas; Scheithauer Werner; Lang Fritz; Laengle Friedrich; Kornek Gabriela V
Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer.
Bernhard Jürg; Dietrich Daniel; Scheithauer Werner; Gerber Daniela; Bodoky György; Ruhstaller Thomas; Glimelius Bengt; Bajetta Emilio; Schüller Johannes; Saletti Piercarlo; Bauer Jean; Figer Arie; Pestalozzi Bernhard C; Köhne Claus-Henning; Mingrone Walter; Stemmer Salomon M; Tàmas Karin; Kornek Gabriela V; Koeberle Dieter; Herrmann Richard;
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
Gruenberger Brigit; Tamandl Dietmar; Schueller Johannes; Scheithauer Werner; Zielinski Christoph; Herbst Friedrich; Gruenberger Thomas
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Werner Scheithauer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vormittag Laurenz; Gleiss Andreas; Scheithauer Werner; Lang Fritz; Laengle Friedrich; Kornek Gabriela V
Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer.
Oncology 2009;77(2):140-6.
2008: Bernhard Jürg; Dietrich Daniel; Scheithauer Werner; Gerber Daniela; Bodoky György; Ruhstaller Thomas; Glimelius Bengt; Bajetta Emilio; Schüller Johannes; Saletti Piercarlo; Bauer Jean; Figer Arie; Pestalozzi Bernhard C; Köhne Claus-Henning; Mingrone Walter; Stemmer Salomon M; Tàmas Karin; Kornek Gabriela V; Koeberle Dieter; Herrmann Richard;
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3695-701.
2008: Gruenberger Brigit; Tamandl Dietmar; Schueller Johannes; Scheithauer Werner; Zielinski Christoph; Herbst Friedrich; Gruenberger Thomas
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1830-5.
2008: Hess Viviane; Glimelius Bengt; Grawe Philipp; Dietrich Daniel; Bodoky György; Ruhstaller Thomas; Bajetta Emilio; Saletti Piercarlo; Figer Arie; Scheithauer Werner; Herrmann Richard
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.
The lancet oncology 2008;9(2):132-8.
2008: Gruenberger Birgit; Scheithauer Werner; Punzengruber Robert; Zielinski Christoph; Tamandl Dietmar; Gruenberger Thomas
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.
BMC cancer 2008;8():120.
2007: Vormittag Laurenz; Kornek Gabriela V; Gruhsmann Barbara; Lenauer Alfred; Föger Andreas; Depisch Dieter; Lang Fritz; Scheithauer Werner
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Anti-cancer drugs 2007;18(6):709-12.
2007: Herrmann Richard; Bodoky György; Ruhstaller Thomas; Glimelius Bengt; Bajetta Emilio; Schüller Johannes; Saletti Piercarlo; Bauer Jean; Figer Arie; Pestalozzi Bernhard; Köhne Claus-Henning; Mingrone Walter; Stemmer Salomon M; Tàmas Karin; Kornek Gabriela V; Koeberle Dieter; Cina Susanne; Bernhard Jürg; Dietrich Daniel; Scheithauer Werner;
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2212-7.
2007: Ulrich-Pur Herbert; Kornek Gabriela V; Haider Karin; Kwasny Werner; Payrits Thomas; Dworan Nina; Vormittag Laurenz; Depisch Dieter; Lang Fritz; Scheithauer Werner
Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(2):208-13.
2006: Wenzel Catharina; Urbauer Eleonora; Schwarz Christoph; Funk Georg; Oehler Leopold; Kornek Gabriela V; Scheithauer Werner
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.
Anti-cancer drugs 2006;17(7):865-8.
2006: Gruenberger Thomas; Gruenberger Birgit; Scheithauer Werner
Neoadjuvant therapy with bevacizumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2592-3; author reply 2593-4.
2006: Schmid Katharina E; Kornek Gabriela V; Scheithauer Werner; Binder Susanne
Update on ocular complications of systemic cancer chemotherapy.
Survey of ophthalmology 2006;51(1):19-40.
2005: Schuell B; Gruenberger T; Kornek G V; Dworan N; Depisch D; Lang F; Schneeweiss B; Scheithauer W
Side effects during chemotherapy predict tumour response in advanced colorectal cancer.
British journal of cancer 2005;93(7):744-8.
2005: Puhalla Harald; Schuell Birgit; Pokorny Herwig; Kornek Gabriela Verena; Scheithauer Werner; Gruenberger Thomas
Treatment and outcome of intrahepatic cholangiocellular carcinoma.
American journal of surgery 2005;189(2):173-7.
2004: Scheithauer Werner; Blum Joanne
Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.
Oncology (Williston Park, N.Y.) 2004;18(9):1161-8, 1173; discussion 1173-6, 1181-4.
2004: Kornek G V; Schuell B; Laengle F; Gruenberger T; Penz M; Karall K; Depisch D; Lang F; Scheithauer W
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):478-83.
2004: Scheithauer W
Esophageal cancer: chemotherapy as palliative therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv97-100.
2003: Schüll B; Scheithauer W; Kornek G V
Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
Onkologie 2003;26(6):578-80.
2003: Wöhrer S; Drach J; Hejna M; Scheithauer W; Dirisamer A; Püspök A; Chott A; Raderer M
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1758-61.
2003: Schmid K E; Kornek G V; Schüll B; Raderer M; Lenauer A; Depisch D; Lang F; Scheithauer W
Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed.
Onkologie 2003;26(3):255-8.
2003: Ulrich-Pur H; Raderer M; Verena Kornek G; Schüll B; Schmid K; Haider K; Kwasny W; Depisch D; Schneeweiss B; Lang F; Scheithauer W
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma.
British journal of cancer 2003;88(8):1180-4.
2003: Scheithauer Werner; Kornek Gabriela V; Raderer Markus; Schüll Birgit; Schmid Katharina; Kovats Erwin; Schneeweiss Bruno; Lang Fritz; Lenauer Alfred; Depisch Dieter
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1307-12.
2003: Gedlicka C; Kornek G V; Schmid K; Scheithauer W
Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):339-40.
2003: Scheithauer W; Schüll B; Ulrich-Pur H; Schmid K; Raderer M; Haider K; Kwasny W; Depisch D; Schneeweiss B; Lang F; Kornek G V
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):97-104.
2003: Schüll Birgit; Kornek Gabriela V; Schmid Katharina; Raderer Markus; Hejna Michael; Lenauer Alfred; Depisch Dieter; Lang Fritz; Scheithauer Werner
Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer.
Oncology 2003;65(3):211-7.
2002: Scheithauer Werner
Review of gemcitabine in biliary tract carcinoma.
Seminars in oncology 2002;29(6 Suppl 20):40-5.
2002: Scheithauer W; Kornek G V; Raderer M; Schüll B; Schmid K; Längle F; Huber H
Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1583-9.
2002: Schüll B; Kornek G V; Schmid K; Raderer M; Ulrich-Pur H; Fiebiger W; Schneeweiss B; Lenauer A; Depisch D; Scheithauer W
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.
Onkologie 2002;25(4):358-62.
2002: Gedlicka C; Scheithauer W; Schüll B; Kornek G V
Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3359-61.
2002: Ulrich-Pur Herbert; Jech Barbara; Scheithauer Werner; Kornek Gabriela Verena; Huber Heinz
[Drug therapy of colorectal carcinoma]
Wiener klinische Wochenschrift 2002;114(10-11):368-76.
2002: Kornek G V; Raderer M; Schüll B; Fiebiger W; Gedlicka C; Lenauer A; Depisch D; Schneeweiss B; Lang F; Scheithauer W
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer.
British journal of cancer 2002;86(12):1858-63.
2002: Gedlicka Claudia; Schüll Birgit; Formanek Michael; Kornfehl Johannes; Burian Martin; Knerer Birgit; Selzer Edgar; Scheithauer Werner; Kornek Gabriela V
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies.
Anti-cancer drugs 2002;13(5):491-5.
2002: Kornek Gabriela V; Haider Karin; Kwasny Werner; Raderer Markus; Schüll Birgit; Payrits Thomas; Depisch Dieter; Kovats Erwin; Lang Fritz; Scheithauer Werner
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1051-6.
2002: Fiebiger W C; Scheithauer W; Traub T; Kurtaran A; Gedlicka C; Kornek G V; Virgolini I; Raderer M
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Scandinavian journal of gastroenterology 2002;37(2):222-5.
2002: Puhalla H; Bareck E; Scheithauer W; Ploner M; Stiglbauer W; Depisch D
[Therapy of gallbladder carcinoma. Experience of a central hospital]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2002;73(1):50-6.
2002: Scheithauer Werner; Kornek Gabriela V; Raderer Markus; Ulrich-Pur Herbert; Fiebiger Wolfgang; Gedlicka Claudia; Schüll Birgit; Brugger Stefan; Schneeweiss Bruno; Lang Fritz; Lenauer Alfred; Depisch Dieter
Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):165-72.
2002: Schüll Birgit; Scheithauer W
[Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination]
Acta medica Austriaca 2002;29(4):124-31.
2002: Scheithauer Werner; Kornek Gabriela V; Brugger Stefan; Ullrich-Pur Herbert; Valencak Julia; Raderer Markus; Fiebiger Wolfgang; Kovats Erwin; Lang Fritz; Depisch Dieter
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.
Cancer investigation 2002;20(1):60-8.
2001: Schüll B; Kornek G V; Scheithauer W
Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1653-4.
2001: Ulrich-Pur H; Kornek G V; Fiebiger W; Gedlicka C; Raderer M; Lenauer A; Depisch D; Lang F; Pidlich J; Scheithauer W
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1269-72.
2001: Scheithauer W; Kornek G V; Schuell B; Ulrich-Pur H; Penz M; Raderer M; Lang F; Schneeweiss B; Lenauer A; Depisch D
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):709-14.
2001: Scheithauer W; Kornek G V; Ulrich-Pur H; Penz M; Raderer M; Salek T; Haider K; Kwasny W; Depisch D
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
Cancer 2001;91(7):1264-71.
2001: Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger W C; Scheithauer W; Virgolini I; Köstler W J; Oberhuber G; Raderer M
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Anticancer research 2001;21(2A):1183-7.
2001: Penz M; Kornek G V; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):421-2.
2001: Kornek G V; Pötter R; Selzer E; Schratter A; Ulrich-Pur H; Rogy M; Kraus G; Scheithauer W
Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
International journal of radiation oncology, biology, physics 2001;49(3):665-71.
2001: Penz M; Kornek G V; Raderer M; Ulrich-Pur H; Fiebiger W; Lenauer A; Depisch D; Krauss G; Schneeweiss B; Scheithauer W
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):183-6.
2001: Kornek G V; Ulrich-Pur H; Penz M; Haider K; Kwasny W; Depisch D; Kovats E; Lang F; Schneeweiss B; Scheithauer W
Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):621-7.
2001: Ulrich-Pur H; Kornek G V; Fiebiger W; Schüll B; Raderer M; Scheithauer W
Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine.
Oncology 2001;60(4):313-5.
2001: Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
Oncology 2001;60(2):141-5.
2000: Kwasny W; Kornek G; Haider K; Valencak J; Ulrich-Pur H; Penz M; Lang F; Depisch D; Scheithauer W
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor.
Breast cancer research and treatment 2000;63(3):235-41.
2000: Ulrich-Pur H; Penz M; Fiebiger W C; Schüll B; Kornek G V; Scheithauer W; Raderer M
Oxaliplatin-induced fever and release of IL-6.
Oncology 2000;59(3):187-9.
2000: Raderer M; Fiebiger W; Wrba F; Scheithauer W
Fatal liver failure after the administration of raltitrexed for cancer chemotherapy: a report of two cases.
Cancer 2000;89(4):890-2.
2000: Hejna M; Kornek G V; Raderer M; Ulrich-Pur H; Fiebiger W C; Marosi L; Schneeweiss B; Greul R; Scheithauer W
Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor.
Cancer 2000;89(3):516-22.
2000: Ulrich-Pur H; Kornek G V; Raderer M; Haider K; Kwasny W; Depisch D; Greul R; Schneeweiss B; Krauss G; Funovics J; Scheithauer W
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.
Cancer 2000;88(11):2505-11.
2000: Raderer M; Valencak J; Osterreicher C; Drach J; Hejna M; Kornek G; Scheithauer W; Brodowicz T; Chott A; Dragosics B
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE.
Cancer 2000;88(9):1979-85.
2000: Raderer M; Kurtaran A; Leimer M; Angelberger P; Niederle B; Vierhapper H; Vorbeck F; Hejna M H; Scheithauer W; Pidlich J; Virgolini I
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1331-6.
2000: Kornek G V; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
British journal of cancer 2000;82(1):98-103.
1999: Scheithauer W; Kornek G V; Raderer M; Hejna M; Valencak J; Miholic J; Kovats E; Lang F; Funovics J; Bareck E; Depisch D
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
British journal of cancer 1999;80(11):1797-802.
1999: Pfeffel F; Stiglbauer W; Depisch D; Oberhuber G; Raderer M; Scheithauer W
Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum.
Digestion 1999;60(4):363-6.
1999: Haider K; Kornek G V; Kwasny W; Weinländer G; Valencak J; Lang F; Püribauer F; Kovats E; Depisch D; Scheithauer W
Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor.
Breast cancer research and treatment 1999;55(3):203-11.
1999: Raderer M; Hejna M H; Valencak J B; Kornek G V; Weinländer G S; Bareck E; Lenauer J; Brodowicz T; Lang F; Scheithauer W
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.
Oncology 1999;56(3):177-80.
1999: Scheithauer W; Kornek G V; Raderer M; Valencak J; Weinländer G; Hejna M; Haider K; Kwasny W; Depisch D
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):902-6.
1999: Raderer M; Hamilton G; Kurtaran A; Valencak J; Haberl I; Hoffmann O; Kornek G V; Vorbeck F; Hejna M H; Virgolini I; Scheithauer W
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results.
British journal of cancer 1999;79(3-4):535-7.
1999: Raderer M; Hejna M H; Kurtaran A; Kornek G V; Valencak J B; Oberhuber G; Vorbeck F; Virgolini I; Scheithauer W
Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide.
The American journal of gastroenterology 1999;94(1):278-9.
1999: Kornek V; Scheithauer W; Glaser C; Toth J; Duman M; Formanek M; Hejna M; Kornfehl J
Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Oncology 1999;56(1):24-7.
1998: Hejna M; Kornek G V; Raderer M; Valencak J; Weinländer G; Fiebiger W; Miholic J; Scheithauer W
5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1309-14.
1998: Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1928-36.
1998: Raderer M; Pangerl T; Leimer M; Valencak J; Kurtaran A; Hamilton G; Scheithauer W; Virgolini I
Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo.
Journal of the National Cancer Institute 1998;90(21):1666-8.
1998: Hejna M; Kornek G V; Raderer M; Marosi L; Schneeweiss B; Greul R; Weinländer G; Valencak J; Huber H; Scheithauer W
Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.
Oncology 1998;55(6):538-42.
1998: Müller C; Pongratz S; Pidlich J; Penner E; Kaider A; Schemper M; Raderer M; Scheithauer W; Ferenci P
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.
European journal of gastroenterology & hepatology 1998;10(10):865-70.
1998: Kornek G V; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
British journal of cancer 1998;78(5):673-8.
1998: Raderer M; Kurtaran A; Yang Q; Meghdadi S; Vorbeck F; Hejna M; Angelberger P; Kornek G; Pidlich J; Scheithauer W; Virgolini I
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(9):1570-5.
1998: Hejna M; Kornek G V; Raderer M; Depisch D; Brodowicz T; Fiebiger W C; Scheithauer W
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.
British journal of cancer 1998;78(6):760-4.
1998: Raderer M; Kurtaran A; Hejna M; Vorbeck F; Angelberger P; Scheithauer W; Virgolini I
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.
British journal of cancer 1998;78(1):1-5.
1998: Raderer M; Kornek G V; Hejna M H; Miholic J; Weinlaender G; Brodowicz T; Fiebiger W C; Valencak J B; Scheithauer W
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen.
European journal of cancer (Oxford, England : 1990) 1998;34(7):1128-30.
1998: Scheithauer W; Kornek G V; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer H M; Schneeweiss B; Depisch D
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
British journal of cancer 1998;77(8):1349-54.
1998: Raderer M; Wrba F; Kornek G; Maca T; Koller D Y; Weinlaender G; Hejna M; Scheithauer W
Association between Helicobacter pylori infection and pancreatic cancer.
Oncology 1998;55(1):16-9.
1997: Raderer M; Kornek G V; Hejna M H; Weinlaender G; Vorbeck F; Fiebiger W C; Scheithauer W
Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):797-9.
1997: Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):908-14.
1997: Weinländer G; Kornek G; Raderer M; Hejna M; Tetzner C; Scheithauer W
Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents: high-dose oral tamoxifen and dexverapamil.
Journal of cancer research and clinical oncology 1997;123(8):452-5.
1996: Raderer M; Pidlich J; Müller C; Pfeffel F; Kornek G V; Hejna M; Scheithauer W
A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2366-8.
1996: Raderer M; Kornek G; Hejna M; Vorbeck F; Weinlaender G; Scheithauer W
Acute pulmonary toxicity associated with high-dose vinorelbine and mitomycin C.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):973-5.
1996: Oberbauer R; Banyai S; Schmidt A; Kornek G; Scheithauer W; Mayer G
Serum tumor markers after renal transplantation.
Transplantation 1996;62(10):1506-9.
1996: Kornek G V; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
British journal of cancer 1996;74(10):1668-73.
1996: Hejna M; Kornek G V; Schratter-Sehn A U; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Cancer 1996;78(8):1646-50.
1996: Virgolini I; Angelberger P; Li S; Yang Q; Kurtaran A; Raderer M; Neuhold N; Kaserer K; Leimer M; Peck-Radosavljevic M; Scheithauer W; Niederle B; Eichler H G; Valent P
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
European journal of nuclear medicine 1996;23(10):1388-99.
1996: Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1480-7.
1996: Virgolini I; Raderer M; Kurtaran A; Angelberger P; Yang Q; Radosavljevic M; Leimer M; Kaserer K; Li S R; Kornek G; Hübsch P; Niederle B; Pidlich J; Scheithauer W; Valent P
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract.
Nuclear medicine and biology 1996;23(6):685-92.
1995: Scheithauer W; Kornek G; Rosen H; Sebesta C; Marcell A; Kwasny W; Karall M; Depisch D
Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):1981-6.
1995: Kornek G; Raderer M; Schenk T; Pidlich J; Schulz F; Globits S; Tetzner C; Scheithauer W
Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma.
Cancer 1995;76(8):1356-62.
1995: Kurtaran A; Li S R; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1875-81.
1995: Virgolini I; Kurtaran A; Raderer M; Leimer M; Angelberger P; Havlik E; Li S; Scheithauer W; Niederle B; Valent P
Vasoactive intestinal peptide receptor scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1732-9.
1995: Kornek G; Schenk T; Raderer M; Djavarnmad M; Scheithauer W
Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.
British journal of cancer 1995;71(1):182-5.
1995: Scheithauer W; Kornek G; Raderer M; Koperna-Mach K; Müller C; Karner J; Kastner J; Tetzner C
Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
Journal of cancer research and clinical oncology 1995;121 Suppl 3():R7-10.
1994: Schenk T; Kaserer K; Scheithauer W
[Extrapulmonary small-cell carcinoma--a rarity?]
Deutsche medizinische Wochenschrift (1946) 1994;119(46):1591-6.
1994: Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
The New England journal of medicine 1994;331(17):1116-21.
1994: Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Cancer 1994;73(6):1562-8.
1994: Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
Cancer research 1994;54(3):690-700.
1994: Kornek G; Raderer M; Depisch D; Haider K; Fazeny B; Dittrich C; Scheithauer W
Amonafide as first-line chemotherapy for metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(3):398-400.
1994: Raderer M; Scheithauer W
Postchemotherapy rheumatism following adjuvant therapy for ovarian cancer.
Scandinavian journal of rheumatology 1994;23(5):291-2.
1993: Raderer M; Scheithauer W
Clinical trials of agents that reverse multidrug resistance. A literature review.
Cancer 1993;72(12):3553-63.
1993: Pirker R; Wallner J; Gsur A; Götzl M; Zöchbauer S; Scheithauer W; Depisch D
MDR1 gene expression in primary colorectal carcinomas.
British journal of cancer 1993;68(4):691-4.
1993: Virgolini I; Kornek G; Höbart J; Li S R; Raolerer M; Bergmann H; Scheithauer W; Pantev T; Angelberger P; Sinzinger H
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
British journal of cancer 1993;68(3):549-54.
1993: Scheithauer W; Schenk T; Czejka M
Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
British journal of cancer 1993;68(1):8-9.
1993: Schenk T; Scheithauer W
[Advances in the prevention and therapy of common chemotherapy-induced side effects]
Deutsche medizinische Wochenschrift (1946) 1993;118(22):831-7.
1993: Kornek G; Schulz F; Depisch D; Rosen H; Kwasny W; Sebesta C; Scheithauer W
A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach.
Cancer 1993;71(7):2177-80.
1993: Scheithauer W; Rosen H; Kornek G V; Sebesta C; Depisch D
Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
BMJ (Clinical research ed.) 1993;306(6880):752-5.
1993: Czejka M J; Schenk T; Scheithauer W
[The combination of epirubicin with d-verapamil and/or tamoxifen in cell cultures]
Die Pharmazie 1993;48(2):148-9.
1993: Scheithauer W; Kornek G; Haider K; Kwasny W; Schenk T; Pirker R; Depisch D
Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.
Breast cancer research and treatment 1993;26(1):49-53.
1993: Scheithauer W; Kornek G; Kastner J; Raderer M; Locker G; Depisch D; Pidlich J; Tetzner C
Phase II study of D-verapamil and doxorubicin in patients with metastatic colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(16):2337-8.
1992: Czejka M J; Schenk T; Scheithauer W
Red blood cell partitioning of N5-methyl-tetrahydrofolic acid after i.v. administration.
Archiv der Pharmazie 1992;325(11):741-2.
1992: Scheithauer W; Pfeffel F; Kornek G; Marczell A; Wiltschke C; Funovics J
A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas.
Cancer 1992;70(7):1864-6.
1992: Virgolini I; Müller C; Höbart J; Scheithauer W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.
Hepatology (Baltimore, Md.) 1992;15(4):593-8.
1992: Kornek G V; Depisch D; Rosen H R; Temsch E M; Scheithauer W
Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
Journal of cancer research and clinical oncology 1992;118(4):318-20.
1991: Scheithauer W; Dittrich C; Kornek G; Haider K; Linkesch W; Gisslinger H; Depisch D
Phase II study of amonafide in advanced breast cancer.
Breast cancer research and treatment 1991;20(1):63-7.
1991: Scheithauer W; Rosen H; Schiessel R; Schüller J; Karall M; Ernst F; Sebesta C; Kornek G; Hentschel E; Marczell A
Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorin.
Cancer 1991;67(5):1294-8.
1990: Scheithauer W; Samonigg H; Depisch D; Schüller J; Hausmaninger H; Wiegele J; Zielinsky C; Stöger H; Haider K; Preis P
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.
Investigational new drugs 1990;8(2):207-10.
1990: Scheithauer W; Kornek G; Haider K; Depisch D
Amonafide in metastatic colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1990;26(8):923-4.
1990: Scheithauer W; Kornek G; Haider K; Depisch D
Unresponsiveness of pancreatic adenocarcinoma to antioestrogen therapy.
European journal of cancer (Oxford, England : 1990) 1990;26(7):851-2.
1989: Adlassnig K P; Scheithauer W
Performance evaluation of medical expert systems using ROC curves.
Computers and biomedical research, an international journal 1989;22(4):297-313.
1989: Ludvik B; Scheithauer W; Wrba F; Schratter M; Schiessel R; Schernthaner G
[Gestagen receptor-positive, solid-cystic acinar-cell tumor of the pancreas]
Deutsche medizinische Wochenschrift (1946) 1989;114(23):903-6.
1987: Adlassnig K P; Horak W; Kolarz G; Scheithauer W; Peichl P; Hay U; Grabner H; Marksteiner A; Sachs P; Gröger I
[Medical expert and consultation systems: review and examples for their use]
Acta medica Austriaca 1987;14(5):136-43.
1986: Adlassnig K P; Kolarz G; Scheithauer W; Grabner H
Approach to a hospital-based application of a medical expert system.
Medical informatics = Médecine et informatique 1986;11(3):205-23.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Werner Scheithauer

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Werner Scheithauer (preview)

All Publications